(Q34455280)

2 August 2017

1 reference

title

Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology (English)

1 reference

2 August 2017

0 references

1 reference

E T Jaikaran

1

1 reference

2 August 2017

A Clark

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Biochimica et Biophysica Acta

2 August 2017

published in

1 reference

2 August 2017

volume

1537

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

179-203

1 reference

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Role of islet amyloid polypeptide secretion in insulin-resistant humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Renal elimination of islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

[Amyloid of islets of Langerhans and its relation to diabetes mellitus (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Non-linkage of the islet amyloid polypeptide gene with Type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Acute application of human amylin, unlike beta-amyloid peptides, kills undifferentiated PC12 cells by apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid peptides are toxic via a common oxidative mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid beta peptide induces necrosis rather than apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Cross-sectional and longitudinal relationship between obesity, hypertension and coronary heart disease in Micronesian Nauruans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Promotion of beta-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Solvent effects on self-assembly of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Insular Amyloidosis and Diabetes Mellitus in Macaca Nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Effects of sequential proline substitutions on amyloid formation by human amylin20-29.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The molecular basis of amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Missense mutation of amylin gene (S20G) in Japanese NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid Fibril Formation from Full-Length and Fragments of Amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Proteoglycans and amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The P-Component of Amyloid of Human Islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Apolipoprotein E and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

A feline model of experimentally induced islet amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The meteoric rise of regulated intracellular proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Lysosomes and pancreatic islet function. A quantitative estimation of crinophagy in the mouse pancreatic B-cell

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Fine structure of islets of Langerhans in insular amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Human type 2 diabetes: morphological evidence for abnormal beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Oophorectomy promotes islet amyloid formation in human islet amyloid polypeptide transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Characterization of the human islet amyloid polypeptide/amylin gene transcripts: Identification of a new polyadenylation site

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Inhibitory effect of pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Regulation of islet amyloid polypeptide in human pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

Amyloid fibrils from muscle myoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900078-3

7 January 2021

10.1016/S0925-4439(01)00078-3

Identifiers

DOI

1 reference

2 August 2017

1 reference